PglB function and glycosylation efficiency is temperature dependent when the pgl locus is integrated in the Escherichia coli chromosome

• Published in: Microbial cell factories Vol. 21; no. 1; pp. 6 - 14
• Main Authors: Terra, Vanessa S., Mauri, Marta, Sannasiddappa, Thippeswamy H., Smith, Alexander A., Stevens, Mark P., Grant, Andrew J., Wren, Brendan W., Cuccui, Jon
• Format: Journal Article
• Language: English
• Published: London BioMed Central 05.01.2022; BioMed Central Ltd; BMC
• Subjects: Antibiotics; Antigens; Applied Microbiology; Bacteria; Bacterial proteins; Bacterial Proteins - genetics; Bacterial Proteins - metabolism; Bacterial Vaccines; Biological conjugation; Biotechnology; Body temperature; Campylobacter; Campylobacter jejuni - genetics; Campylobacter jejuni - immunology; Chemistry; Chemistry and Materials Science; Chromosomes; Chromosomes - genetics; Cloning; Conjugate vaccines; E coli; Efficiency; Enzymology; Escherichia coli; Escherichia coli - genetics; Escherichia coli - metabolism; Gene expression; Genetic aspects; Genetic Engineering; Glycan; Glycoconjugates; Glycoconjugates - metabolism; Glycosylation; Membrane Proteins - genetics; Metabolic engineering; Metabolic Engineering - methods; Methods; Microbial Genetics and Genomics; Microbiological research; Microbiology; Mutation; One health; Pathogens; Peptides; PGCT; PglB; Physiological aspects; Plasmids; Polysaccharides; Polysaccharides, Bacterial - genetics; Poultry; Proteins; Pseudomonas aeruginosa; Substrates; Temperature; Temperature dependence; Temperature effects; Toxins; Transcription; Vaccines; United Kingdom; Temperature; One health; Poultry; PglB; Vaccine; Biological conjugation; PGCT
• ISSN: 1475-2859; 1475-2859
• DOI: 10.1186/s12934-021-01728-7

Background Campylobacter is an animal and zoonotic pathogen of global importance, and a pressing need exists for effective vaccines, including those that make use of conserved polysaccharide antigens. To this end, we adapted Protein Glycan Coupling Technology (PGCT) to develop a versatile Escherichia coli strain capable of generating multiple glycoconjugate vaccine candidates against Campylobacter jejuni . Results We generated a glycoengineering E. coli strain containing the conserved C. jejuni heptasaccharide coding region integrated in its chromosome as a model glycan. This methodology confers three advantages: (i) reduction of plasmids and antibiotic markers used for PGCT, (ii) swift generation of many glycan-protein combinations and consequent rapid identification of the most antigenic proteins or peptides, and (iii) increased genetic stability of the polysaccharide coding-region. In this study, by using the model glycan expressing strain, we were able to test proteins from C. jejuni , Pseudomonas aeruginosa (both Gram-negative), and Clostridium perfringens (Gram-positive) as acceptors. Using this pgl integrant E. coli strain, four glycoconjugates were readily generated. Two glycoconjugates, where both protein and glycan are from C. jejuni (double - hit vaccines) , and two glycoconjugates, where the glycan antigen is conjugated to a detoxified toxin from a different pathogen (single-hit vaccines). Because the downstream application of Live Attenuated Vaccine Strains (LAVS) against C. jejuni is to be used in poultry, which have a higher body temperature of 42 °C, we investigated the effect of temperature on protein expression and glycosylation in the E. coli pgl integrant strain. Conclusions We determined that glycosylation is temperature dependent and that for the combination of heptasaccharide and carriers used in this study, the level of PglB available for glycosylation is a step limiting factor in the glycosylation reaction. We also demonstrated that temperature affects the ability of PglB to glycosylate its substrates in an in vitro glycosylation assay independent of its transcriptional level.